Qianyuan Pharmaceutical: Issuance of Shares to Specific Targets in 2023, Diluted Immediate Returns and Remediation Measures and Related Entity Commitments (Revised Draft)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.